Inventor
HAWLEY RONALD CHARLES
US43 patents
⚠️ This page may combine multiple inventors who share the name “HAWLEY RONALD CHARLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROCHE PALO ALTO LLC
20 patentsUS7858632B2Dec 28, 2010
Diaminopyrimidines as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC28 citations92
US8008313B2Aug 30, 2011
Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases
ROCHE PALO ALTO LLC20 citations91
US7595405B2Sep 29, 2009
Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC7 citations74
US6846828B2Jan 25, 2005
Aminopyrimidine and aminopyridine anti-inflammation agents
ROCHE PALO ALTO LLC6 citations73
US8048905B2Nov 1, 2011
Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC4 citations63
US7786110B2Aug 31, 2010
Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC5 citations63
US7285561B2Oct 23, 2007
Imidazo-substituted compounds as p38 kinase inhibitors
ROCHE PALO ALTO LLC1 citations62
US7157580B2Jan 2, 2007
Aminopyrimidine and aminopyridine anti-inflammation agents
ROCHE PALO ALTO LLC2 citations62
US7081462B2Jul 25, 2006
Imidazo-substituted compounds as p38 kinase inhibitors
ROCHE PALO ALTO LLC1 citations62
US6949560B2Sep 27, 2005
Imidazo-substituted compounds as p38 kinase inhibitors
ROCHE PALO ALTO LLC3 citations62
US10201525B2Feb 12, 2019
Tetrazole-substituted arylamides as PX2 and PX2/3 antagonists
ROCHE PALO ALTO LLC0 citations52
US9896439B2Feb 20, 2018
Pyrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC0 citations52
US9849136B2Dec 26, 2017
Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC0 citations52
US9617254B2Apr 11, 2017
Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC0 citations52
US9512089B2Dec 6, 2016
Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC0 citations52
US9505726B2Nov 29, 2016
Substituted biphenyl amides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC1 citations52
US7989637B2Aug 2, 2011
Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC0 citations52
US9556127B2Jan 31, 2017
Diaminopyrimidines as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC1 citations51
US7285559B2Oct 23, 2007
Imidazo-substituted compounds as p38 kinase inhibitors
ROCHE PALO ALTO LLC0 citations51
US7858654B2Dec 28, 2010
Imidazole-substituted arylamides as P2X3 and P2X2/3 antagonists
ROCHE PALO ALTO LLC0 citations42
AFFERENT PHARMACEUTICALS INC
7 patentsUS10822311B2Nov 3, 2020
Pyrimidines and variants thereof, and uses therefor
AFFERENT PHARMACEUTICALS INC3 citations71
US10662162B2May 26, 2020
Pyrimidines and variants thereof, and uses therefor
AFFERENT PHARMACEUTICALS INC2 citations71
US11230533B2Jan 25, 2022
Crystalline salts and polymorphs of a P2X3 antagonist
AFFERENT PHARMACEUTICALS INC0 citations62
US10676444B2Jun 9, 2020
Crystalline salts and polymorphs of a P2X3 antagonist
AFFERENT PHARMACEUTICALS INC1 citations62
US11591315B2Feb 28, 2023
Substituted pyrazole-pyrimidines, variants thereof, and uses therefore
AFFERENT PHARMACEUTICALS INC0 citations60
US11230532B2Jan 25, 2022
Pyrimidines and variants thereof, and uses therefor
AFFERENT PHARMACEUTICALS INC0 citations60
US10988460B2Apr 27, 2021
Substituted pyrazole-pyrimidines, variants thereof, and uses therefore
AFFERENT PHARMACEUTICALS INC0 citations60
BROKA CHRIS ALLEN
4 patentsUS8846705B2Sep 30, 2014
Diaminopyrimidines as P2X3 and P2X2/3 antagonists
BROKA CHRIS ALLEN11 citations82
US8524725B2Sep 3, 2013
Methods of using diaminopyrimidine as P2X3 and P2X⅔ receptor modulators for treatment of respiratory and gastrointestinal diseases
BROKA CHRIS ALLEN9 citations82
US8895589B2Nov 25, 2014
Pyridinyl amides as P2X3 and P2X2/3 inhibitors
BROKA CHRIS ALLEN0 citations51
US8283383B2Oct 9, 2012
Biphenyl amides as P2X3 and P2X2/3 antagonists
BROKA CHRIS ALLEN0 citations51
CHEN LI
4 patentsUS8841336B2Sep 23, 2014
Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
CHEN LI4 citations73
US8501933B2Aug 6, 2013
Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists
CHEN LI1 citations52
US8440708B2May 14, 2013
Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists
CHEN LI1 citations52
US8440673B2May 14, 2013
Pyrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
CHEN LI0 citations52
SAVIRA PHARMACEUTICALS GMBH
4 patentsUS9505758B2Nov 29, 2016
Substituted 1,5-naphthyridines as endonuclease inhibitors
SAVIRA PHARMACEUTICALS GMBH0 citations49
US9199987B2Dec 1, 2015
Substituted naphthyridines for the treatment, amelioration or prevention of a viral disease
SAVIRA PHARMACEUTICALS GMBH0 citations49
US9045486B2Jun 2, 2015
Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease
SAVIRA PHARMACEUTICALS GMBH0 citations39
US8952039B2Feb 10, 2015
Pyridone derivatives and their use in the treatment, ameloriation or prevention of a viral disease
SAVIRA PHARMACEUTICALS GMBH0 citations38
DILLON MICHAEL PATRICK
3 patentsUS8193368B2Jun 5, 2012
Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
DILLON MICHAEL PATRICK2 citations61
US8846945B2Sep 30, 2014
Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
DILLON MICHAEL PATRICK0 citations51
US9593128B2Mar 14, 2017
Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
DILLON MICHAEL PATRICK0 citations47